Goat Anti-Human IgG H&L (HRP) (ab6858)
Key features and details
- Goat Anti-Human IgG H&L (HRP)
- Conjugation: HRP
- Host species: Goat
- Isotype: IgG
- Suitable for: ICC/IF, Dot blot, ELISA, IHC-P, IHC-Fr, Immunomicroscopy, WB
Related conjugates and formulations
製品の概要
-
製品名
Goat Anti-Human IgG H&L (HRP)
IgG 二次抗体 製品一覧 -
由来種
Goat -
ターゲット生物種
Human -
アプリケーション
適用あり: ICC/IF, Dot blot, ELISA, IHC-P, IHC-Fr, Immunomicroscopy, WBmore details -
免疫原
human IgG whole molecule
-
標識
HRP
製品の特性
-
製品の状態
Liquid -
保存方法
Shipped at 4°C. Store at +4°C. -
バッファー
pH: 6.50
Preservative: 0.01% Gentamicin sulphate
Constituents: 0.42% Tripotassium orthophosphate, 0.87% Sodium chloride, 1% BSA -
Concentration information loading...
-
精製度
Affinity purified -
特記事項(精製)
This product was prepared from monospecific antiserum by immunoaffinity chromatography using Human IgG coupled to agarose beads followed by solid phase adsorption(s) to remove any unwanted reactivities. -
特記事項(標識)
Horseradish Peroxidase (HRP) -
ポリ/モノ
ポリクローナル -
アイソタイプ
IgG -
研究分野
アプリケーション
The Abpromise guarantee
Abpromise保証は、 次のテスト済みアプリケーションにおけるab6858の使用に適用されます
アプリケーションノートには、推奨の開始希釈率がありますが、適切な希釈率につきましてはご検討ください。
アプリケーション | Abreviews | 特記事項 |
---|---|---|
ICC/IF |
1/1000 - 1/5000.
|
|
Dot blot |
Use at an assay dependent concentration.
|
|
ELISA |
Use at an assay dependent dilution.
|
|
IHC-P |
Use at an assay dependent concentration.
|
|
IHC-Fr |
Use at an assay dependent concentration.
|
|
Immunomicroscopy |
Use at an assay dependent concentration.
|
|
WB |
1/5000 - 1/25000.
|
特記事項 |
---|
ICC/IF
1/1000 - 1/5000. |
Dot blot
Use at an assay dependent concentration. |
ELISA
Use at an assay dependent dilution. |
IHC-P
Use at an assay dependent concentration. |
IHC-Fr
Use at an assay dependent concentration. |
Immunomicroscopy
Use at an assay dependent concentration. |
WB
1/5000 - 1/25000. |
画像
プロトコール
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
データシートおよび資料
-
Datasheet download
参考文献 (46)
ab6858 は 46 報の論文で使用されています。
- Ranjbaran H et al. Comparison of neutralization potency across passive immunotherapy approaches as potential treatments for emerging infectious diseases. Heliyon 10:e23478 (2024). PubMed: 38226283
- Zheng Q et al. A bifunctional molecule-assisted synthesis of mimics for use in probing the ubiquitination system. Nat Protoc 18:530-554 (2023). PubMed: 36323865
- Zhang X et al. Altered genome‑wide hydroxymethylation analysis for neoadjuvant chemoradiotherapy followed by surgery in esophageal cancer. Exp Ther Med 25:29 (2023). PubMed: 36561617
- Osaka T et al. Cross-Reactivity of Antibodies in Intravenous Immunoglobulin Preparation for Protection against SARS-CoV-2. Microorganisms 11:N/A (2023). PubMed: 36838436
- Okano F et al. Identification of Membrane-expressed CAPRIN-1 as a Novel and Universal Cancer Target, and Generation of a Therapeutic Anti-CAPRIN-1 Antibody TRK-950. Cancer Res Commun 3:640-658 (2023). PubMed: 37082579